Top compounds associated with response to DIDO1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib FIMM pan-cancer AAC -0.018 0.9
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.0038 0.9
mRNA etoposide GDSC1000 pan-cancer AAC -0.0036 0.9
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.0036 0.9
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.0032 0.9
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0033 0.9
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.0038 0.9
mRNA ML006 CTRPv2 pan-cancer AAC -0.0037 0.9
mRNA Axitinib CTRPv2 pan-cancer AAC -0.0034 0.9
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.0047 0.9
Download CSV